Craig Reynolds MD in Ocala, Florida

Home Florida Ocala

Craig Reynolds MD has Hematology/oncology as his primary medical specialty. Their primary office is: 1630 Se 18th St Building 600 in Ocala, Florida.

They're a part of the: Florida Cancer Specialists And Research Institute, Llc medical group which has around 380 members. You can call their office at 352-369-0181 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Washington University School Of Medicine and graduated in 1987 (around 37 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Craig H Reynolds MD Office Phone and Directions

Craig Reynolds MD
Florida Cancer Specialists And Research Institute, Llc
1630 Se 18th St Building 600
Ocala, Florida 34471
352-369-0181

Patient Ratings
Please rate your experience with Craig Reynolds MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 352-369-0181

Enter a starting address:

Healthcare Info for Craig Reynolds MD

Medical School: Washington University School Of Medicine
Graduation Year: 1987
The Primary Medical Specialty for Craig Reynolds MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 37
PAC (PECOS ID)#: 6002824133
NPI #: 1235199878
NPI Created On: 03/27/2006
NPI Last Updated Listed as: 08/19/2022
Primary Taxonomy Code: 207RH0000X
License Number:
ME63906
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Ct scan chest with contrast
Ct scan of abdomen and pelvis with contrast
Nuclear medicine study with ct imaging skull base to mid-thigh
Blood test, comprehensive group of blood chemicals
Blood test, lipids (cholesterol and triglycerides)
Carcinoembryonic antigen (cea) protein level
Cyanocobalamin (vitamin b-12) level
Ferritin (blood protein) level
Folic acid level
Gammaglobulin (immune system protein) measurement
Iron level
Iron binding capacity
Lactate dehydrogenase (enzyme) level
Magnesium level
Nephelometry, test method using light
Psa (prostate specific antigen) measurement
Protein measurement, serum
Blood test, thyroid stimulating hormone (tsh)
Transferrin (iron binding protein) level

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788018363

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788018365

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788018367

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788018369

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788018371

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: RYBREVANT

Open Associated Drug #1: 57894-501-01

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788018379

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788018373

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788018375

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788018377

Being Disputed:: No

Product Related: No

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788018381

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Hematology/oncology Professionals in Ocala

1.
Ravi Koti MD

2494 Sw 19th Ave Rd
Ocala, FL
Central Florida Cancer And Blood Center Pa

2.
Andrew Weber

3130 Sw 32nd Ave
Ocala, FL
Ocala Oncology Center Pl

3.
Maury Berger MD

3130 Sw 32nd Ave
Ocala, FL
Ocala Oncology Center Pl

4.
Anju Vasudevan MD

3130 Sw 32nd Ave
Ocala, FL
Ocala Oncology Center Pl

5.
Anju Vasudevan MD

9401 Sw State Rd
Ocala, FL
Ocala Oncology Center Pl

6.
Daniel Patterson MD

3256 S Pine Ave
Ocala, FL

Providers in Florida Cancer Specialists And Research Institute, Llc

1.Patrick Acevedo Md

1503 Buenos Aires Blvd
The Villages Fl 32159-6823
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

2.Patrick Acevedo Md

6420 W Newberry Rd E Wing
Gainesville Fl 32605-4308
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

3.Patrick Acevedo Md

1396 Whisper Cir
Sebring Fl 33870-1204
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

4.Patrick Acevedo Md

2848 Ctr Pointe Dr
Fort Myers Fl 33916-9521
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

5.Patrick Acevedo Md

901 Tamiami Trl S
Venice Fl 34285-3668
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

6.Patrick Acevedo Md

2231 Hwy 44 West 203
Inverness Fl 34453-3879
Florida Cancer Specialists And Research Institute, Llc
Medical Oncology

View all 380 members of Florida Cancer Specialists And Research Institute, Llc medical group